Novel quinazoline derivatives. II. A new anti-inflammatory agent, SL-512.
D000700:Analgesics / Q000494:pharmacology / Q000627:therapeutic use; D000818:Animals; D000893:Anti-Inflammatory Agents / Q000138:chemical synthesis / Q000494:pharmacology* / Q000627:therapeutic use; D001168:Arthritis / Q000188:drug therapy; D002199:Capillary Permeability / Q000187:drug effects; D003521:Cyclopropanes / Q000138:chemical synthesis / Q000494:pharmacology / Q000627:therapeutic use; D004487:Edema / Q000188:drug therapy; D004890:Erythema / Q000188:drug therapy; D006099:Granuloma / Q000188:drug therapy; D006168:Guinea Pigs; D007416:Intestinal Perforation / Q000188:drug therapy; D007928:Lethal Dose 50; D008297:Male; D008528:Mefenamic Acid / Q000627:therapeutic use; D051379:Mice; D010538:Peritonitis / Q000188:drug therapy; D010653:Phenylbutazone / Q000627:therapeutic use; D011799:Quinazolines / Q000138:chemical synthesis / Q000494:pharmacology* / Q000627:therapeutic use; D051381:Rats
D000700:Analgesics; D000893:Anti-Inflammatory Agents; D003521:Cyclopropanes; D011799:Quinazolines; D008528:Mefenamic Acid; D010653:Phenylbutazone